BRIDGEWATER, N.J., Jan. 30, 2019 /PRNewswire/ -- Continued research and development is critical to advancing care for people with rare diseases who have a significant need for earlier diagnosis, better disease management opportunities, and new treatment options. Sanofi Genzyme, the...
from PR Newswire: https://prn.to/2ToDwcw
No comments:
Post a Comment